Kearney Brian 4
4 · PARDES BIOSCIENCES, INC. · Filed Feb 3, 2023
Insider Transaction Report
Form 4
Kearney Brian
Chief Development Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-02-01+156,250→ 156,250 totalExercise: $2.08Exp: 2033-02-01→ Common Stock (156,250 underlying)
Footnotes (1)
- [F1]Option vests over four years with 1/48th of the shares subject to such option vesting and becoming exercisable in substantially equal monthly installments on the 1st day of each month after the Grant Date (02/01/2023), subject to continued service relationship.